Trupanion (NASDAQ:TRUP – Free Report) had its price target lowered by Stifel Nicolaus from $45.00 to $42.00 in a research note released on Tuesday,Benzinga reports. Stifel Nicolaus currently has a hold rating on the financial services provider’s stock.
Other analysts also recently issued research reports about the company. Wall Street Zen upgraded Trupanion from a “hold” rating to a “buy” rating in a research note on Saturday, November 8th. Weiss Ratings reissued a “sell (d+)” rating on shares of Trupanion in a research report on Thursday, November 13th. Cantor Fitzgerald raised shares of Trupanion to a “hold” rating in a report on Wednesday, August 13th. Finally, Piper Sandler boosted their target price on shares of Trupanion from $62.00 to $67.00 and gave the company an “overweight” rating in a research report on Friday, August 8th. Two investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $54.00.
Read Our Latest Research Report on Trupanion
Trupanion Price Performance
Trupanion (NASDAQ:TRUP – Get Free Report) last released its earnings results on Thursday, November 6th. The financial services provider reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.89 by ($0.76). The company had revenue of $366.92 million for the quarter, compared to analysts’ expectations of $361.58 million. Trupanion had a return on equity of 3.31% and a net margin of 0.81%.The firm’s revenue for the quarter was up 12.0% on a year-over-year basis. During the same period in the prior year, the firm posted $0.03 EPS. Trupanion has set its Q4 2025 guidance at EPS. FY 2025 guidance at EPS. As a group, equities analysts forecast that Trupanion will post 0.13 earnings per share for the current fiscal year.
Insiders Place Their Bets
In other news, CFO Fawwad Qureshi sold 2,800 shares of the firm’s stock in a transaction dated Tuesday, August 26th. The stock was sold at an average price of $45.56, for a total transaction of $127,568.00. Following the sale, the chief financial officer directly owned 6,451 shares in the company, valued at $293,907.56. This trade represents a 30.27% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Darryl Rawlings sold 30,369 shares of the company’s stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $44.70, for a total value of $1,357,494.30. Following the completion of the transaction, the director directly owned 1,413,281 shares of the company’s stock, valued at $63,173,660.70. The trade was a 2.10% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 70,645 shares of company stock worth $3,128,119. Company insiders own 5.42% of the company’s stock.
Hedge Funds Weigh In On Trupanion
Large investors have recently added to or reduced their stakes in the stock. Federated Hermes Inc. purchased a new stake in shares of Trupanion during the third quarter worth about $33,000. Pilgrim Partners Asia Pte Ltd purchased a new position in shares of Trupanion in the third quarter valued at approximately $39,000. Nisa Investment Advisors LLC boosted its stake in shares of Trupanion by 44.1% in the second quarter. Nisa Investment Advisors LLC now owns 980 shares of the financial services provider’s stock worth $54,000 after acquiring an additional 300 shares during the last quarter. AlphaQuest LLC increased its position in shares of Trupanion by 940.6% during the first quarter. AlphaQuest LLC now owns 1,051 shares of the financial services provider’s stock worth $39,000 after purchasing an additional 950 shares in the last quarter. Finally, Kelleher Financial Advisors acquired a new position in Trupanion in the 3rd quarter valued at $74,000.
Trupanion Company Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Featured Articles
- Five stocks we like better than Trupanion
- Why Invest in 5G? How to Invest in 5G Stocks
- What’s on the Thanksgiving Table? A Stock Pick for Every Course
- What is the FTSE 100 index?
- Why Home Depot’s Pain Could Be a Long-Term Investor’s Gain
- Which Wall Street Analysts are the Most Accurate?
- Qualcomm’s Bulls Are Running Out of Room to Be Wrong
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
